Geode Capital Management LLC Has $122.75 Million Stock Position in Dolby Laboratories $DLB

Geode Capital Management LLC grew its position in Dolby Laboratories (NYSE:DLBFree Report) by 15.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,885,246 shares of the electronics maker’s stock after buying an additional 254,250 shares during the quarter. Geode Capital Management LLC’s holdings in Dolby Laboratories were worth $122,749,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in DLB. AQR Capital Management LLC lifted its position in shares of Dolby Laboratories by 51.8% in the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock worth $128,935,000 after purchasing an additional 592,282 shares in the last quarter. First Trust Advisors LP raised its position in Dolby Laboratories by 22.7% during the third quarter. First Trust Advisors LP now owns 1,518,657 shares of the electronics maker’s stock valued at $109,905,000 after acquiring an additional 281,214 shares in the last quarter. Vanguard Group Inc. raised its position in Dolby Laboratories by 2.7% during the third quarter. Vanguard Group Inc. now owns 7,756,924 shares of the electronics maker’s stock valued at $561,369,000 after acquiring an additional 203,411 shares in the last quarter. State Street Corp raised its position in Dolby Laboratories by 8.7% during the second quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock valued at $167,906,000 after acquiring an additional 180,072 shares in the last quarter. Finally, Goldman Sachs Group Inc. raised its position in Dolby Laboratories by 218.8% during the first quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker’s stock valued at $20,043,000 after acquiring an additional 171,288 shares in the last quarter. 58.56% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, CFO Robert J. Park sold 4,895 shares of Dolby Laboratories stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $56.68, for a total transaction of $277,448.60. Following the sale, the chief financial officer owned 81,490 shares in the company, valued at $4,618,853.20. The trade was a 5.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP John D. Couling sold 7,666 shares of Dolby Laboratories stock in a transaction on Monday, June 1st. The stock was sold at an average price of $55.62, for a total transaction of $426,382.92. Following the sale, the senior vice president owned 118,727 shares in the company, valued at $6,603,595.74. This represents a 6.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 39,791 shares of company stock worth $2,231,653 over the last three months. 37.93% of the stock is currently owned by corporate insiders.

Dolby Laboratories Trading Down 0.6%

Shares of Dolby Laboratories stock opened at $53.70 on Friday. The company’s fifty day simple moving average is $58.97 and its 200-day simple moving average is $62.63. The company has a market cap of $5.08 billion, a price-to-earnings ratio of 21.23 and a beta of 0.81. Dolby Laboratories has a 1 year low of $52.45 and a 1 year high of $77.00.

Dolby Laboratories (NYSE:DLBGet Free Report) last announced its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.31 by $0.06. The business had revenue of $395.63 million for the quarter, compared to the consensus estimate of $385.80 million. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. Dolby Laboratories’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter last year, the company posted $1.34 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. As a group, research analysts forecast that Dolby Laboratories will post 3.21 earnings per share for the current fiscal year.

Dolby Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were paid a dividend of $0.36 per share. The ex-dividend date was Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a yield of 2.7%. Dolby Laboratories’s payout ratio is currently 56.92%.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on DLB shares. Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Barrington Research reaffirmed an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a research report on Monday, April 27th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Friday, March 27th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $90.75.

View Our Latest Research Report on DLB

Dolby Laboratories Company Profile

(Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

See Also

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.